Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
iShares MSCI Japan ETF
EWJ
$23.1B
| $1.74M | ﹤0.01% |
25,741
-264
| -1% | -$18.1K |
|
|
TACO
3077
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $1.74M | ﹤0.01% |
173,351
-2,869
| -2% | -$30.1K |
|
3078
First Trust Senior Loan Fund ETF
FTSL
$2.33B
| $1.73M | ﹤0.01% |
36,114
+6,612
| +22% | +$317K |
|
3079
Cricut
CRCT
$1.22B
| $1.73M | ﹤0.01% |
+40,687
| New | +$1.14M |
|
3080
iRadimed
IRMD
$1.1B
| $1.73M | ﹤0.01% |
58,928
-76
| -0.1% | -$2.09K |
|
|
AKRO
3081
DELISTED
Akero Therapeutics
AKRO
| $1.73M | ﹤0.01% |
69,721
+15,073
| +28% | +$423K |
|
3082
Compass Diversified
CODI
$956M
| $1.73M | ﹤0.01% |
67,710
| – | – |
|
3083
Honda
HMC
$40.7B
| $1.73M | ﹤0.01% |
53,692
-242
| -0.4% | -$7.52K |
|
3084
Pliant Therapeutics
PLRX
$66.3M
| $1.73M | ﹤0.01% |
59,290
-116,658
| -66% | -$3.63M |
|
3085
International Seaways
INSW
$4.81B
| $1.73M | ﹤0.01% |
89,987
-28,109
| -24% | -$546K |
|
3086
Vanguard Communication Services ETF
VOX
$5.89B
| $1.72M | ﹤0.01% |
11,986
+1,399
| +13% | +$193K |
|
3087
Neuronetics
STIM
$219M
| $1.72M | ﹤0.01% |
107,531
+41,664
| +63% | +$576K |
|
3088
iShares New York Muni Bond ETF
NYF
$1.41B
| $1.72M | ﹤0.01% |
29,444
+8,181
| +38% | +$476K |
|
3089
Phathom Pharmaceuticals
PHAT
$759M
| $1.72M | ﹤0.01% |
50,819
+9,597
| +23% | +$344K |
|
3090
Sana Biotechnology
SANA
$1.02B
| $1.72M | ﹤0.01% |
87,301
+38,196
| +78% | +$866K |
|
3091
Lufax Holding
LU
$1.3B
| $1.72M | ﹤0.01% |
37,936
-8,125
| -18% | -$409K |
|
3092
Gossamer Bio
GOSS
$76.2M
| $1.71M | ﹤0.01% |
210,538
-23,737
| -10% | -$206K |
|
|
BELFB
3093
Bel Fuse Inc Class B
BELFB
$4.18B
| $1.71M | ﹤0.01% |
118,407
-29,447
| -20% | -$484K |
|
3094
Peoples Financial Services
PFIS
$716M
| $1.7M | ﹤0.01% |
40,009
-431
| -1% | -$18.5K |
|
3095
KB Financial Group
KB
$42.1B
| $1.7M | ﹤0.01% |
34,503
+28,203
| +448% | +$1.41M |
|
3096
Harvard Bioscience
HBIO
$30.5M
| $1.69M | ﹤0.01% |
20,335
+4,559
| +29% | +$323K |
|
3097
Seer Inc
SEER
$117M
| $1.69M | ﹤0.01% |
51,610
+652
| +1% | +$25.7K |
|
3098
Xtrackers Short Duration High Yield Bond ETF
SHYL
$267M
| $1.69M | ﹤0.01% |
35,155
+28,689
| +444% | +$1.37M |
|
3099
International Money Express
IMXI
$433M
| $1.69M | ﹤0.01% |
113,835
-8,878
| -7% | -$133K |
|
3100
Alaunos Therapeutics
TCRT
$4.79M
| $1.69M | ﹤0.01% |
4,270
-2,374
| -36% | -$1.11M |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.